| ||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Copyright © 2009. National Academy of Sciences. All rights reserved. Terms of Use and Privacy Statement |
Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 26
stucly nested within the cohort of vaccinees). The committee applauds CDC for developing the
evaluation and research plan so quickly, and looks forward to receiving further communication
from CDC about these issues.
CONCLUDING REMARKS
in closing, the committee reiterates its key recommendations.
Advancing the smallpox vaccination program should occur with a focus on cleiPining and then
achieving national and local preparedness against a possible smallpox attack.
Every effort should be macie to evaluate on a national scale the program's implementation,
and most importantly, its safety.
The committee wishes to thank you for the continuing opportunity to be of assistance to
the Centers for Disease Control and Prevention as it works to protect the nation's health.
Brian L. Strom, Committee Chair
Kristine M. Gebbie, Committee Vice Chair
Robert B. Wallace, Committee Vice Chair
Committee on Smallpox Vaccination Program Implementation
.
6
26
!
Representative terms from entire chapter:
smallpox vaccination